Efficient virus detection utilizing chitin-immobilized nanobodies synthesized in Ustilago maydis.


Journal

Journal of biotechnology
ISSN: 1873-4863
Titre abrégé: J Biotechnol
Pays: Netherlands
ID NLM: 8411927

Informations de publication

Date de publication:
20 Mar 2023
Historique:
received: 12 12 2022
revised: 08 02 2023
accepted: 16 03 2023
medline: 4 4 2023
pubmed: 23 3 2023
entrez: 22 3 2023
Statut: ppublish

Résumé

The COVID-19 pandemic has greatly impacted the global economy and health care systems, illustrating the urgent need for timely and inexpensive responses to pandemic threats in the form of vaccines and antigen tests. Currently, antigen testing is mostly conducted by qualitative flow chromatography or via quantitative ELISA-type assays. The latter mostly utilize materials like protein-adhesive polymers and gold or latex particles. Here we present an alternative ELISA approach using inexpensive, biogenic materials and permitting quick detection based on components produced in the microbial model Ustilago maydis. In this fungus, heterologous proteins like biopharmaceuticals can be exported by fusion to unconventionally secreted chitinase Cts1. As a unique feature, the carrier chitinase binds to chitin allowing its additional use as a purification or immobilization tag. Recent work has demonstrated that nanobodies are suitable target proteins. These proteins represent a very versatile alternative antibody format and can quickly be adapted to detect novel antigens by camelidae immunization or synthetic libraries. In this study, we exemplarily produced different mono- and bivalent SARS-CoV-2 nanobodies directed against the spike protein receptor binding domain (RBD) as Cts1 fusions and screened their antigen binding affinity in vitro and in vivo. Functional nanobody-Cts1 fusions were immobilized on chitin forming an RBD tethering surface. This provides a solid base for future development of inexpensive antigen tests utilizing unconventionally secreted nanobodies as antigen trap and a matching ubiquitous and biogenic surface for immobilization.

Identifiants

pubmed: 36948402
pii: S0168-1656(23)00057-3
doi: 10.1016/j.jbiotec.2023.03.005
pmc: PMC10028217
pii:
doi:

Substances chimiques

Single-Domain Antibodies 0
Chitin 1398-61-4
Chitinases EC 3.2.1.14

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

72-84

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Carbohydr Polym. 2021 Mar 15;256:117549
pubmed: 33483056
Bioengineering (Basel). 2022 Feb 12;9(2):
pubmed: 35200425
Cell. 2020 May 28;181(5):1004-1015.e15
pubmed: 32375025
Protein Expr Purif. 2015 Dec;116:42-9
pubmed: 26297996
Nature. 1975 Dec 18;258(5536):598-9
pubmed: 1678
Nat Med. 2022 Mar;28(3):490-495
pubmed: 35046573
Appl Environ Microbiol. 2022 Mar 8;88(5):e0230321
pubmed: 34985974
Viruses. 2021 Apr 10;13(4):
pubmed: 33920222
J Biotechnol. 2014 Dec 10;191:165-75
pubmed: 24997354
Nat Methods. 2009 May;6(5):343-5
pubmed: 19363495
Biochem Biophys Res Commun. 2021 Oct 15;574:14-19
pubmed: 34425281
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
Anal Bioanal Chem. 2019 Mar;411(9):1703-1713
pubmed: 30734854
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
J Popul Econ. 2021;34(4):1105-1140
pubmed: 34219976
Mar Drugs. 2019 Oct 10;17(10):
pubmed: 31658704
Molecules. 2020 Dec 16;25(24):
pubmed: 33339290
J Biol Chem. 1998 Apr 24;273(17):10567-77
pubmed: 9553117
Virusdisease. 2020 Jun;31(2):75-79
pubmed: 32368569
PLoS One. 2017 May 11;12(5):e0177592
pubmed: 28494030
AIMS Microbiol. 2020 Aug 26;6(3):280-304
pubmed: 33134745
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
Methods Mol Biol. 2016;1459:149-60
pubmed: 27665557
Nature. 2003 Nov 27;426(6965):450-4
pubmed: 14647384
Clin Infect Dis. 2021 Dec 6;73(11):2065-2072
pubmed: 33906236
Int J Mol Sci. 2017 Apr 29;18(5):
pubmed: 28468279
Cell. 2020 Aug 20;182(4):812-827.e19
pubmed: 32697968
FASEB J. 2021 Nov;35(11):e21970
pubmed: 34637549
Mol Cell Biol. 1988 May;8(5):2159-65
pubmed: 2455217
Fertil Steril. 2020 Aug;114(2):233-238
pubmed: 32650948
Biotechnol J. 2020 Sep;15(9):e2000151
pubmed: 32578939
iScience. 2022 Mar 18;25(3):103960
pubmed: 35224467
Biosens Bioelectron. 2020 Sep 1;163:112291
pubmed: 32421630
J Biotechnol. 2012 Oct 15;161(2):80-91
pubmed: 22446315
Nat Struct Mol Biol. 2020 Sep;27(9):846-854
pubmed: 32661423
Nature. 2016 Mar 3;531(7592):118-21
pubmed: 26935699
Acta Biomater. 2020 May;108:87-96
pubmed: 32268237
Adv Virus Res. 2016;96:29-57
pubmed: 27712627
Science. 2021 Feb 12;371(6530):
pubmed: 33436526
Front Cell Dev Biol. 2022 Jan 10;9:816335
pubmed: 35083222
Front Bioeng Biotechnol. 2020 Apr 08;8:293
pubmed: 32322579
Mar Drugs. 2015 Mar 02;13(3):1133-74
pubmed: 25738328
Gene. 1997 Jun 19;192(2):271-81
pubmed: 9224900
Int J Mol Sci. 2019 Jan 22;20(3):
pubmed: 30678160
Vet Immunol Immunopathol. 2009 Mar 15;128(1-3):178-83
pubmed: 19026455
Annu Rev Biochem. 2013;82:775-97
pubmed: 23495938
J Biotechnol. 2018 Oct 20;284:37-51
pubmed: 30063952
Anal Chem. 2020 Aug 18;92(16):11305-11309
pubmed: 32605363
Biochem Med (Zagreb). 2021 Jun 15;31(2):020601
pubmed: 34140830
Microb Cell Fact. 2021 Dec 28;20(1):232
pubmed: 34963459
BMJ. 2021 Nov 29;375:n2943
pubmed: 34845008
Methods Mol Biol. 2015;1318:61-7
pubmed: 26160564
Nat Commun. 2020 Mar 27;11(1):1620
pubmed: 32221306
Appl Microbiol Biotechnol. 2010 Jul;87(4):1255-70
pubmed: 20532762
Front Microbiol. 2020 Jul 07;11:1529
pubmed: 32733418
Nat Commun. 2020 Nov 4;11(1):5588
pubmed: 33149112
ACS Cent Sci. 2020 Nov 25;6(11):2046-2052
pubmed: 33269329
Eur J Clin Microbiol Infect Dis. 2021 May;40(5):1063-1071
pubmed: 33534090
Appl Biochem Biotechnol. 2011 Nov;165(5-6):1169-77
pubmed: 21845444
Cell. 2020 May 14;181(4):894-904.e9
pubmed: 32275855
Appl Microbiol Biotechnol. 2006 May;70(5):505-16
pubmed: 16496138
J Chromatogr A. 2016 Jul 29;1457:50-8
pubmed: 27342136

Auteurs

Magnus Philipp (M)

Institute for Microbiology, Heinrich Heine University Düsseldorf, Universitätsstraße 1, 40225 Düsseldorf, Germany.

Lisa Müller (L)

Institute of Virology, Medical Faculty, Heinrich Heine University Düsseldorf, Universitätsstraße 1, 40225 Düsseldorf, Germany.

Marcel Andrée (M)

Institute of Virology, Medical Faculty, Heinrich Heine University Düsseldorf, Universitätsstraße 1, 40225 Düsseldorf, Germany.

Kai P Hussnaetter (KP)

Institute for Microbiology, Heinrich Heine University Düsseldorf, Universitätsstraße 1, 40225 Düsseldorf, Germany.

Heiner Schaal (H)

Institute of Virology, Medical Faculty, Heinrich Heine University Düsseldorf, Universitätsstraße 1, 40225 Düsseldorf, Germany.

Michael Feldbrügge (M)

Institute for Microbiology, Heinrich Heine University Düsseldorf, Universitätsstraße 1, 40225 Düsseldorf, Germany.

Kerstin Schipper (K)

Institute for Microbiology, Heinrich Heine University Düsseldorf, Universitätsstraße 1, 40225 Düsseldorf, Germany. Electronic address: kerstin.schipper@uni-duesseldorf.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH